{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T11:06:28Z","timestamp":1774004788184,"version":"3.50.1"},"reference-count":14,"publisher":"PeerJ","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Shenzhen Science and Technology Program","award":["JCYJ20240813151606009"],"award-info":[{"award-number":["JCYJ20240813151606009"]}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"crossref","award":["2023A1515011365"],"award-info":[{"award-number":["2023A1515011365"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shenzhen High-level Hospital Construction Fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background and Purpose<\/jats:title>\n                    <jats:p>\n                      Considering the limitations of current homogeneity index (HI) in multi-target plans, we have redefined the volume (V)\n                      <jats:sub>PTV<\/jats:sub>\n                      in the formula for calculating the HI value of target volumes. This redefinition could provide a reference for clinical applications.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and Material<\/jats:title>\n                    <jats:p>\n                      Since the three widely used HI formulas may not fully capture dose homogeneity in multi-target treatment plans, we have redefined the V\n                      <jats:sub>PTV<\/jats:sub>\n                      in the calculation formulas, which may allow for a better assessment of HI for the multi-target radiotherapy plans. Fifteen clinically treated breast cancer (BC) with conserving surgery patients and fifteen nasopharyngeal carcinoma (NPC) patients were chosen. We calculated the V\n                      <jats:sub>PTV<\/jats:sub>\n                      with the name of V\n                      <jats:sub>PTVpro<\/jats:sub>\n                      and the HI\n                      <jats:sub>pro1<\/jats:sub>\n                      , HI\n                      <jats:sub>pro2<\/jats:sub>\n                      , HI\n                      <jats:sub>pro3<\/jats:sub>\n                      . A paired, two-tailed non-parametric Wilcoxon signed-rank test was utilized to compare V\n                      <jats:sub>PTVori<\/jats:sub>\n                      and V\n                      <jats:sub>PTVpro<\/jats:sub>\n                      , HI\n                      <jats:sub>ori1<\/jats:sub>\n                      and HI\n                      <jats:sub>pro1<\/jats:sub>\n                      , HI\n                      <jats:sub>ori2<\/jats:sub>\n                      and HI\n                      <jats:sub>pro2<\/jats:sub>\n                      , HI\n                      <jats:sub>ori3<\/jats:sub>\n                      and HI\n                      <jats:sub>pro3<\/jats:sub>\n                      . The correlations between HI\n                      <jats:sub>ori1<\/jats:sub>\n                      and HI\n                      <jats:sub>pro1<\/jats:sub>\n                      , HI\n                      <jats:sub>ori2<\/jats:sub>\n                      and HI\n                      <jats:sub>pro2<\/jats:sub>\n                      , HI\n                      <jats:sub>ori3<\/jats:sub>\n                      and HI\n                      <jats:sub>pro3<\/jats:sub>\n                      were also analyzed. We conducted a questionnaire survey among a panel of six senior radiation oncologists and physicists to validate the clinical applicability of this study.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      For Planning Target Volume (PTV) of BC and PTV1 of NPC, the V\n                      <jats:sub>PTVpro<\/jats:sub>\n                      were significantly smaller than the V\n                      <jats:sub>PTVori<\/jats:sub>\n                      and HI\n                      <jats:sub>pro<\/jats:sub>\n                      were significantly lower than HI\n                      <jats:sub>ori<\/jats:sub>\n                      . The correlation coefficient values of HI\n                      <jats:sub>ori1<\/jats:sub>\n                      -HI\n                      <jats:sub>pro1<\/jats:sub>\n                      , HI\n                      <jats:sub>ori2<\/jats:sub>\n                      -HI\n                      <jats:sub>pro2<\/jats:sub>\n                      , and HI\n                      <jats:sub>ori3<\/jats:sub>\n                      -HI\n                      <jats:sub>pro3<\/jats:sub>\n                      showed variations, though all demonstrated positive correlations with statistically significant p-values &lt;0.01. The results for these two target volumes revealed a consistent pattern: the HI\n                      <jats:sub>ori1<\/jats:sub>\n                      -HI\n                      <jats:sub>pro1<\/jats:sub>\n                      pair exhibited the highest correlation coefficient values, while HI\n                      <jats:sub>ori2<\/jats:sub>\n                      -HI\n                      <jats:sub>pro2<\/jats:sub>\n                      consistently showed the lowest values. Meanwhile, clinical validation by the expert panel found that the V\n                      <jats:sub>PTVpro<\/jats:sub>\n                      and HI\n                      <jats:sub>pro<\/jats:sub>\n                      in this study do not affect clinical plan selection. All experts agreed that, compared to V\n                      <jats:sub>PTVori<\/jats:sub>\n                      and HI\n                      <jats:sub>ori<\/jats:sub>\n                      , V\n                      <jats:sub>PTVpro<\/jats:sub>\n                      and HI\n                      <jats:sub>pro<\/jats:sub>\n                      better align with their clinical practice for evaluating multi-target radiotherapy plans.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The V\n                      <jats:sub>PTVpro<\/jats:sub>\n                      calculation subtracts the overlapping high-dose target volume from the low-dose target volume. This adjustment is intended to enable a more accurate assessment of dose HI specifically within the low-dose target. Additionally, the V\n                      <jats:sub>PTVpro<\/jats:sub>\n                      is also applicable for HI calculation in single-target volume. We suggest using the V\n                      <jats:sub>PTVpro<\/jats:sub>\n                      to calculate the HI of the target for multi-target plans such as BC with conserving surgery and NPC. Meanwhile, we recommend employing formula 1 for the calculation of HI among the three formulas.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.7717\/peerj.21005","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T08:56:39Z","timestamp":1773996999000},"page":"e21005","source":"Crossref","is-referenced-by-count":0,"title":["A modified homogeneity index for multi- target radiotherapy plans by subtracting high-dose subvolumes"],"prefix":"10.7717","volume":"14","author":[{"given":"Yong","family":"Sang","sequence":"first","affiliation":[{"name":"Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Dang","sequence":"additional","affiliation":[{"name":"Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianan","family":"Wu","sequence":"additional","affiliation":[{"name":"Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajun","family":"Cai","sequence":"additional","affiliation":[{"name":"Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoye","family":"Su","sequence":"additional","affiliation":[{"name":"Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanling","family":"Wu","sequence":"additional","affiliation":[{"name":"Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4443","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"10.7717\/peerj.21005\/ref-1","doi-asserted-by":"publisher","first-page":"100659","DOI":"10.1016\/j.phro.2024.100659","article-title":"Technical feasibility of delivering a simultaneous integrated boost in partial breast irradiation","volume":"32","author":"Burton","year":"2024","journal-title":"Physics and Imaging in Radiation Oncology"},{"issue":"2","key":"10.7717\/peerj.21005\/ref-2","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.meddos.2018.02.005","article-title":"Monaco treatment planning system tools and optimization processes","volume":"43","author":"Clements","year":"2018","journal-title":"Medical Dosimetry"},{"key":"10.7717\/peerj.21005\/ref-3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jicru\/10.1.Report83","article-title":"Prescribing, recording, and reporting photon-beam intensity- modulated radiation therapy (IMRT). ICRU Report 83","volume":"10","author":"International Commission on Radiation Units and Measurements (ICRU)","year":"2010","journal-title":"Journal of the ICRU"},{"issue":"1","key":"10.7717\/peerj.21005\/ref-4","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1037\/0033-2909.111.1.172","article-title":"Comparing correlated correlation coefficients","volume":"111","author":"Meng","year":"1992","journal-title":"Psychological Bulletin"},{"issue":"1","key":"10.7717\/peerj.21005\/ref-5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.radonc.2014.11.030","article-title":"ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer","volume":"114","author":"Offersen","year":"2015","journal-title":"Radiotherapy and Oncology"},{"issue":"Suppl 33","key":"10.7717\/peerj.21005\/ref-6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3171\/jns.2000.93.supplement_3.0219","article-title":"A simple scoring ratio to index the conformity of radiosurgical treatment plans. Technical note","volume":"93","author":"Paddick","year":"2000","journal-title":"Journal of Neurosurgery"},{"issue":"3","key":"10.7717\/peerj.21005\/ref-7","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.rpor.2020.03.002","article-title":"Plan evaluation indices: a journey of evolution","volume":"25","author":"Patel","year":"2020","journal-title":"Reports of Practical Oncology and Radiotherapy"},{"issue":"1","key":"10.7717\/peerj.21005\/ref-8","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.meddos.2020.09.005","article-title":"The robustness of VMAT radiotherapy for breast cancer with tissue deformations","volume":"46","author":"Rossi","year":"2021","journal-title":"Medical Dosimetry"},{"issue":"3","key":"10.7717\/peerj.21005\/ref-9","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/s0360-3016(96)00601-3","article-title":"A conformation number to quantify the degree of conformality in brachytherapy and external beam irradiation: application to the prostate","volume":"37","author":"Van\u2019t Riet","year":"1997","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"3","key":"10.7717\/peerj.21005\/ref-10","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/S1470-2045(18)30813-1","article-title":"Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial","volume":"20","author":"Wang","year":"2019","journal-title":"The Lancet Oncology"},{"issue":"6","key":"10.7717\/peerj.21005\/ref-11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/acm2.13287","article-title":"Effect of auto flash margin on superficial dose in breast conserving radiotherapy for breast cancer","volume":"22","author":"Wang","year":"2021","journal-title":"Journal of Applied Clinical Medical Physics"},{"issue":"21","key":"10.7717\/peerj.21005\/ref-12","doi-asserted-by":"publisher","first-page":"5057","DOI":"10.7150\/jca.33303","article-title":"Safety and effectiveness of de-escalated radiation dose in T1-3 nasopharyngeal carcinoma: a propensity matched analysis","volume":"10","author":"Wang","year":"2019","journal-title":"Journal of Cancer"},{"issue":"2","key":"10.7717\/peerj.21005\/ref-13","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.ijrobp.2005.06.006","article-title":"Effectiveness of noncoplanar IMRT planning using a parallelized multiresolution beam angle optimization method for paranasal sinus carcinoma","volume":"63","author":"Wang","year":"2005","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"2","key":"10.7717\/peerj.21005\/ref-14","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/s0360-3016(02)04617-5","article-title":"Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas. I: dosimetric results","volume":"56","author":"Wu","year":"2003","journal-title":"International Journal of Radiation Oncology, Biology, Physics"}],"container-title":["PeerJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/peerj.com\/articles\/21005.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/21005.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/21005.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/21005.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T08:56:41Z","timestamp":1773997001000},"score":1,"resource":{"primary":{"URL":"https:\/\/peerj.com\/articles\/21005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":14,"alternative-id":["10.7717\/peerj.21005"],"URL":"https:\/\/doi.org\/10.7717\/peerj.21005","archive":["CLOCKSS","LOCKSS","Portico"],"relation":{},"ISSN":["2167-8359"],"issn-type":[{"value":"2167-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]},"article-number":"e21005"}}